India's economy will recover following the containment of COVID-19 pandemic, and ongoing reforms would keep the country's growth rate ahead of peers, Niti Aayog Vice Chairman Rajiv Kumar said on Tuesday.
Kumar was speaking at the virtual launch of a report titled - Towards a Clean Energy Economy: Post-COVID-19 Opportunities in India's Energy and Mobility Sectors - prepared by government think tank Niti Aayog and Rocky Mountain Institute (RMI).
"India's economy will recover following the containment of the COVID-19 pandemic," he said.
Last week, the IMF had projected a sharp contraction of 4.5 per cent for India's growth in 2020, citing unprecedented coronavirus pandemic that has nearly stalled all economic activities, but had said the country is expected to bounce back in 2021 with a robust six per cent growth rate.
"India's strong democratic institutions promote policy stability. Ongoing economic reforms, if executed well, should keep the country's growth rate ahead of peers," Kumar added.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
Several economists, brokerages and multilateral agencies have pointed to a deep contraction to india, triggered by the strict lockdown announced to stem the spread of deadly coronavirus.
Speaking at the event, Niti Aayog CEO Amitabh Kant said clean energy will be a major driver of India's economic recovery and international competitiveness.
"We must look at how to leverage our domestic innovation ecosystem to bring value to the country and industry in this new normal.
"We have recommended specific actions by which India can revive two of our economic powerhouses - the transport and power sectors - and emerge stronger," Kant said.
The report said electric vehicles market in India may experience a shift as consumers seek affordable products amid COVID-19, and it could make manufacturers resume production for conventional vehicles.
It also said there may be delays in electric vehicles (EV) production as manufacturers focus on reviving demand and producing BS-VI vehicles, while curbs on imports of Chinese components may lead to disruptions in EV manufacturing.
"Auto sales could decrease by as much as 45 per cent in the financial year 2020–21. EV production could be affected in the short term due to lower demand and supply-chain disruptions with BNEF estimating an 18 per cent decrease in global EV sales in 2020.
"The EV market may experience other shifts. For example, there is an expectation of demand for more affordable EV products. This potential shift in consumer preferences may affect manufacturers' investment and production decisions. Ultimately, resuming production levels for conventional vehicles and EVs will depend on demand revival, supply-chain reactivation, and access to the labour force," the report said.
Lower disposable incomes and a tendency towards cash saving will lead to reduced demand for EV in the short-term, the report said, adding "some OEMs' customers are pushing back their EV business plans by two or more years".
On the impact on EV supply chains, the report said, "There may be delays in EV production as manufacturers focus on reviving demand and producing BS-VI vehicles. Curbs on imports of Chinese components may lead to disruptions in EV manufacturing".
It also highlighted the consequences of policy changes, stating "many state EV policies and e-bus projects may be delayed due to other priorities and social-distancing challenges".
Stressing that the emerging situation and challenges in the context of COVID-19 has and will continue to disrupt business as usual in the mobility sector, the report said the impact of the pandemic on passenger and freight segments, as well as the auto industry, raise several questions.
These include whether the overall demand for mobility will fall in the short to medium-term, will ridership of public and shared transport modes decline and will private modes be preferred?
It also pondered whether lack of auto sales will cause a severe hit to the supply chain and a growing call for self-sufficiency lead to a push to create local supply chains.
"Will the Prime Minister's call for domestic manufacturing and localisation attract investments at a time when a recession is looming? Would the new mobility ecosystem propelled by startups be able to survive the crisis," it wondered.